Insider · CIK 0001799784

Gaiero David G

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001799784

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-04	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,373 sh	—	—	83,052
2024-03-04	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,373 sh	$1.69	+$4,010.37	102,391
2024-02-29	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,746 sh	$1.69	+$8,020.74	100,018
2024-02-29	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,239 sh	$1.68	+$5,441.52	95,272
2024-02-29	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,239 sh	—	—	16,196
2024-02-29	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,746 sh	—	—	85,425
2023-12-11	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,373 sh	$1.69	+$4,010.37	92,033
2023-12-11	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,373 sh	—	—	90,171
2023-12-11	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,620 sh	$1.68	+$2,721.6	89,660
2023-12-11	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,620 sh	—	—	19,435
2023-11-20	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−52.6K sh	—	—	21,055
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+52.6K sh	$1.68	+$88.3K	66,684
2023-11-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+21.4K sh	$1.69	+$36.1K	88,040
2023-11-20	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−21.4K sh	—	—	92,544
2023-02-03	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+114K sh	—	—	113,900
2023-01-13	Cyteir Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+5,000 sh	$1.49	+$7,450	9,100
2022-02-22	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+23K sh	—	—	23,000
2021-12-20	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,100 sh	—	—	73,639
2021-12-20	Cyteir Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,100 sh	$1.68	+$6,888	4,100
2020-03-03	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Interim CFO	AAward	+18K sh	—	—	18,000
2020-02-03	WVEWave Life Sciences, Inc.S Sale	Interim CFO	SSale	−651 sh	$7.00	−$4,557	6,392

Recent filings

Accepted (ET)
Mar 54
Gaiero David G0001209191-24-004439
SEC(opens sec.gov)
Dec 144
Gaiero David G0001209191-23-058610
SEC(opens sec.gov)
Nov 224
Gaiero David G0001209191-23-056425
SEC(opens sec.gov)
Feb 74
Gaiero David G0001209191-23-007536
SEC(opens sec.gov)
Feb 74
Gaiero David G0001209191-23-007528
SEC(opens sec.gov)
Feb 244
Gaiero David G0000899243-22-007631
SEC(opens sec.gov)
Mar 54
Gaiero David G0000899243-20-007284
SEC(opens sec.gov)

Companies

Address

C/O WAVE LIFE SCIENCES LTD., 733 CONCORD AVE.

CAMBRIDGE, MA, 02138